Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus.

The Journal of comparative neurology | 2010

The development of the hypothalamic paraventricular nucleus (PVN) involves several factors that work together to establish a cell group that regulates neuroendocrine functions and behaviors. Several molecular markers were noted within the developing PVN, including estrogen receptors (ER), neuronal nitric oxide synthase (nNOS), and brain-derived neurotrophic factor (BDNF). By contrast, immunoreactive gamma-aminobutyric acid (GABA) was found in cells and fibers surrounding the PVN. Two animal models were used to test the hypothesis that GABA works through GABA(A) and GABA(B) receptors to influence the development of the PVN. Treatment with bicuculline to decrease GABA(A) receptor signaling from embryonic day (E) 10 to E17 resulted in fewer cells containing immunoreactive (ir) ERalpha in the region of the PVN vs. control. GABA(B)R1 receptor subunit knockout mice were used to examine the PVN at P0 without GABA(B) signaling. In female but not male GABA(B)R1 subunit knockout mice, the positions of cells containing ir ERalpha shifted from medial to lateral compared with wild-type controls, whereas the total number of ir ERalpha-containing cells was unchanged. In E17 knockout mice, ir nNOS cells and fibers were spread over a greater area. There was also a significant decrease in ir BDNF in the knockout mice in a region-dependent manner. Changes in cell position and protein expression subsequent to disruption of GABA signaling may be due, in part, to changes in nNOS and BDNF signaling. Based on the current study, the PVN can be added as another site where GABA exerts morphogenetic actions in development.

Pubmed ID: 20506472 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions

Neuropeptide Y Antibody (antibody)

RRID:AB_2307354

This polyclonal targets Neuropeptide Y

View all literature mentions

CRH (antibody)

RRID:AB_2314235

This unknown targets

View all literature mentions

GABABR1 (GP311) (antibody)

RRID:AB_2314490

This unknown targets

View all literature mentions

Anti-Estrogen Receptor alpha (antibody)

RRID:AB_310305

This polyclonal targets Estrogen Receptor alpha (C1355)

View all literature mentions

Monoclonal Anti-Calbindin-D-28K antibody produced in mouse (antibody)

RRID:AB_476894

This monoclonal targets Calbindin-D-28K antibody produced in mouse

View all literature mentions

Vasopressin Antibody (antibody)

RRID:AB_572219

This polyclonal targets Arg Vasopressin

View all literature mentions

BDNF (N-20) (antibody)

RRID:AB_630940

This monoclonal targets BDNF

View all literature mentions

Neuropeptide Y Antibody (antibody)

RRID:AB_2307354

This polyclonal targets Neuropeptide Y

View all literature mentions